Our work demonstrated that RBMS1 could upregulate IL-6 transactivation by influencing histone modification in promoter regions and then induce autocrine IL-6/JAK2/STAT3 signaling to facilitate GC metastasis. The gene discussed is JAK2; the disease is gastric cancer.